Eran Ovadya
Director of Finance/CFO bei NUREXONE BIOLOGIC INC.
Vermögen: - $ am 31.03.2024
Profil
Mr. Eran Ovadya is a Chief Financial Officer at NurExone Biologic, Inc. Mr. Ovadya was previously employed as a Chief Financial Officer by Silexion Therapeutics Ltd.
and a Chief Financial Officer by VVT Medical Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUREXONE BIOLOGIC INC
-.--% | 08.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Eran Ovadya
| Unternehmen | Position | Beginn |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Director of Finance/CFO | 15.06.2022 |
Ehemalige bekannte Positionen von Eran Ovadya
| Unternehmen | Position | Ende |
|---|---|---|
| VVT Medical Ltd. | Director of Finance/CFO | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director of Finance/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
